Showing results (121-130 of 210) with videos related to

Sort By:
Pageof 21
Behavioral Neuroscience|August 30, 2008
Behavioral profile of a heterozygous mutant mouse model for EGF-like domain neuregulin 1Liesl Duffy, Emily Cappas, Anna Scimone, et al.
Psychopharmacology|March 1, 2014
Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 miceDavid Cheng, Jac Kee Low, Warren Logge, et al.
Behavioural Brain Research|December 10, 2013
Novel behavioural characteristics of female APPSwe/PS1ΔE9 double transgenic miceDavid Cheng, Jac Kee Low, Warren Logge, et al.
Journal of Clinical Psychopharmacology|June 14, 2021
Citalopram and Cannabidiol: In Vitro and In Vivo Evidence of Pharmacokinetic Interactions Relevant to the Treatment of Anxiety Disorders in Young PeopleLyndsey L Anderson, Peter T Doohan, Lachlan Oldfield, et al.
Molecular Neurobiology|November 10, 2012
Stress-induced grey matter loss determined by MRI is primarily due to loss of dendrites and their synapsesMustafa S Kassem, Jim Lagopoulos, Tim Stait-Gardner, et al.
Journal of Psychopharmacology (Oxford, England)|September 28, 2018
Cannabidiol treatment reduces the motivation to self-administer methamphetamine and methamphetamine-primed relapse in ratsGracie L Hay, Sarah J Baracz, Nicholas A Everett, et al.
Neuropharmacology|October 30, 2020
The anticonvulsant zonisamide positively modulates recombinant and native glycine receptors at clinically relevant concentrationsSteven O Devenish, Bryony L Winters, Lyndsey L Anderson, et al.
Cannabis and Cannabinoid Research|May 17, 2021
Evaluation of the Possible Anticonvulsant Effect of Δ<sup>9</sup>-Tetrahydrocannabinolic Acid in Murine Seizure ModelsMelissa J Benson, Lyndsey L Anderson, Ivan K Low, et al.
Brain Research|August 30, 2006
Effects of chronic risperidone treatment on the striatal protein profiles in ratsElizabeth O'Brien, Irina Dedova, Liesl Duffy, et al.
Pageof 21